MELINTA THERAPEUTICS, INC. /NEW/

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$311.1M

202 transactions

Summary

MELINTA THERAPEUTICS, INC. /NEW/ is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $303.3MSales: $6.9M41 insiders

Date	Insider	Type	Value
2019-02-22	Joint reporting: Ferro Kevin; Vatera Healthcare Partners LLC; Vatera Capital Management LLC	Buy	$75.0M
2019-06-27	JOHNSON JOHN(Chief Executive Officer)	Sell	$72K
2019-06-11	Galeota James JR	A	$0
2019-06-11	Koestler Thomas P	A	$0
2019-06-11	ZACCARDELLI DAVID	A	$0
2019-06-11	GILL DAVID N	A	$0
2019-06-11	DOWNEY BRUCE	A	$0
2019-06-11	Ferro Kevin	A	$0
2019-05-22	JOHNSON JOHN	M	$0
2019-05-22	JOHNSON JOHN	M	$0
2019-05-16	Milligan Peter J(Chief Financial Officer)	A	$0
2019-05-16	Cammarata Sue(Chief Medical Officer)	A	$0
2019-02-22	JOHNSON JOHN(Chief Executive Officer)	A	$0
2018-11-30	DOWNEY BRUCE	A	$0
2018-10-26	JOHNSON JOHN(Interim CEO)	A	$0
2018-10-26	JOHNSON JOHN(Interim CEO)	A	$0
2018-09-21	Milligan Peter J(Chief Financial Officer)	A	$0
2018-06-12	Wechsler Daniel Mark(See Remarks)	A	$0
2018-06-12	Estrem Paul(Chief Financial Officer)	A	$0
2018-06-12	Duffy Erin(Chief Scientific Officer)	A	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

MELINTA THERAPEUTICS, INC. /NEW/ — Contributions, Lobbying & Contracts | Poliscope